Valuation: Zydus Lifesciences Limited

Capitalization 1LCr 1.04TCr 889.46Cr 813.82Cr 772.87Cr 1.42TCr 1.45TCr 9.74TCr 3.78TCr 47TCr 3.89TCr 3.8TCr 1,64500Cr P/E ratio 2026 *
21.7x
P/E ratio 2027 * 24.1x
Enterprise value 99TCr 1.03TCr 883.82Cr 808.66Cr 767.97Cr 1.41TCr 1.44TCr 9.68TCr 3.75TCr 47TCr 3.86TCr 3.78TCr 1,63400Cr EV / Sales 2026 *
3.79x
EV / Sales 2027 * 3.33x
Free-Float
24.84%
Yield 2026 *
0.82%
Yield 2027 * 0.76%
1 day-2.04%
1 week+5.43%
Current month+11.12%
1 month+4.99%
3 months+9.31%
6 months+6.03%
Current year+8.39%
1 week 925.1
Extreme 925.1
1,018.8
1 month 890.4
Extreme 890.4
1,018.8
Current year 835.5
Extreme 835.5
1,018.8
1 year 835.5
Extreme 835.5
1,059.05
3 years 484.95
Extreme 484.95
1,324.3
5 years 319
Extreme 319
1,324.3
10 years 202
Extreme 202
1,324.3
Manager TitleAgeSince
Chief Executive Officer 46 27/11/2009
Director of Finance/CFO 65 -
Director of Finance/CFO 56 01/09/2025
Director TitleAgeSince
Director/Board Member 74 06/12/2018
Chairman 73 05/10/2011
Director/Board Member 71 01/08/1997
Change 5d. change 1-year change 3-years change Capi.($)
-2.04%+5.43%+9.79%+91.04% 1.06TCr
+1.47%+3.13%+9.85%+103.62% 4.7TCr
-0.58%+1.32%+68.94%+128.10% 3.73TCr
-0.41%+5.88%-4.91%+54.36% 1.21TCr
+3.61%0.00%+35.33%+120.35% 908.74Cr
-3.79%-1.73%+60.73%-5.92% 750.28Cr
-1.11%-1.19%+18.80%+53.70% 739.23Cr
+0.60%-1.12%+61.53%+284.31% 684.14Cr
-3.74%-7.55%+152.36%+467.63% 602.31Cr
-1.39%-27.43%-11.39%-0.17% 577.44Cr
Average -0.78%-0.14%+40.10%+129.70% 1.5TCr
Weighted average by Cap. -0.08%+1.34%+35.21%+116.83%

Financials

2026 *2027 *
Net sales 26TCr 271.21Cr 233.03Cr 213.21Cr 202.48Cr 372.83Cr 379.18Cr 2.55TCr 989.03Cr 12TCr 1.02TCr 996.3Cr 43TCr 28TCr 294.8Cr 253.29Cr 231.75Cr 220.09Cr 405.25Cr 412.16Cr 2.77TCr 1.08TCr 13TCr 1.11TCr 1.08TCr 47TCr
Net income 4.66TCr 48Cr 42Cr 38Cr 36Cr 66Cr 68Cr 455Cr 176.34Cr 2.2TCr 181.48Cr 177.64Cr 7.68TCr 4.15TCr 43Cr 37Cr 34Cr 32Cr 59Cr 60Cr 405.31Cr 157.08Cr 1.96TCr 161.66Cr 158.24Cr 6.84TCr
Net Debt -632.45Cr -6.57Cr -5.64Cr -5.16Cr -4.9Cr -9.02Cr -9.18Cr -62Cr -24Cr -299.24Cr -25Cr -24Cr -1.04TCr -5.15TCr -53Cr -46Cr -42Cr -40Cr -74Cr -75Cr -503.2Cr -195.02Cr -2.44TCr -200.71Cr -196.46Cr -8.5TCr
Logo Zydus Lifesciences Limited
Zydus Lifesciences Limited is an India-based life-sciences company with positions across pharmaceuticals and consumer wellness, supported by a MedTech franchise and a global footprint across United States, India and other international markets. Its pharmaceutical business includes integrated pharmaceutical operations with business encompassing the entire value chain in research, development, production, marketing and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients, human formulations, and animal health and veterinary. Its consumer products business includes development, production, marketing and distribution of differentiated health and wellness products. It provides biologicals manufacturing sites offering contract development and manufacturing organization services to biopharmaceutical companies globally. Its focused therapy areas include cardiology, anti-diabetes, super specialty areas of oncology and nephrology, and others.
Employees
27,917
Date Price Change Volume
18/26/18 991.10 -2.04% 12,96,063
15/26/15 1,011.70 +2.02% 19,96,110
14/26/14 991.70 +5.58% 45,95,018
13/26/13 939.25 +0.92% 6,80,562
12/26/12 930.65 -2.75% 7,20,954
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
991.10INR
Average target price
994.03INR
Spread / Average Target
+0.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock